Cabaletta Bio, Inc. (CABA)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Steven Nichtberger
Employees:
50
2929 ARCH STREET, SUITE 600, PHILADELPHIA, PA 19104
(267) 759-3100

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its lead product candidate is DSG3-CAART, which is in Phase I clinical trial for the treatment of mucosal pemphigus vulgaris, an autoimmune blistering skin disease, and Hemophilia A with Factor VIII alloantibodies.

Data derived from most recent annual or quarterly report
Market Cap 42.017 Million Shares Outstanding28.977 Million Avg 30-day Volume 327.638 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.45
Price to Revenue0.0 Debt to Equity0.0 EBITDA-98.379 Million
Price to Book Value0.5512 Operating Margin0.0 Enterprise Value-50.389 Million
Current Ratio16.069 EPS Growth-0.211 Quick Ratio15.748
1 Yr BETA 1.4327 52-week High/Low 14.95 / 0.9 Profit Margin0.0
Operating Cash Flow Growth-25.3663 Altman Z-Score1.7661 Free Cash Flow to Firm -30.941 Million
View SEC Filings from CABA instead.

View recent insider trading info

Funds Holding CABA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CABA

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-08-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-02:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-18:
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-02:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-17:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K/A: filed on 2022-03-14:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-03:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-01:
    Item 8.01: Other Events
  • 8-K: filed on 2022-01-10:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    HENRIQUES RICHARD C JR

    • Director
    22,000 2022-06-01 1

    SIMON MARK

    • Director
    22,000 2022-06-01 1

    BOLLARD CATHERINE

    • Director
    22,000 2022-06-01 1

    BRUN SCOTT C.

    • Director
    22,000 2022-06-01 1

    NICHTBERGER STEVEN PRESIDENT & CEO

    • Officer
    • Director
    1,429,160 2022-01-31 2

    MARDA ANUP CHIEF FINANCIAL OFFICER

    • Officer
    135,000 2022-01-18 1

    CHANG DAVID J. CHIEF MEDICAL OFFICER

    • Officer
    135,000 2022-01-18 1

    BINDER GWENDOLYN SEE REMARKS

    • Officer
    160,000 2022-01-18 1

    GERARD MICHAEL GENERAL COUNSEL

    • Officer
    75,000 2022-01-18 3

    DAS ARUN CHIEF BUSINESS OFFICER

    • Officer
    100,000 2022-01-18 2

    5AM VENTURES V, L.P.

    5AM OPPORTUNITIES I (GP), LLC

    5AM OPPORTUNITIES I, L.P.

    5AM PARTNERS V, LLC

    PARMAR KUSH

    ROCKLAGE SCOTT M

    SCHWAB ANDREW J.

    • 10% Owner
    2,064,263 2021-11-01 2

    DANIELS BRIAN

    • Director
    22,000 2021-06-01 0

    STALTER JOHN BRIAN GENERAL COUNSEL

    • Officer
    64,500 2021-03-01 0

    REDMILE GROUP, LLC

    GREEN JEREMY

    • 10% Owner
    No longer subject to file 2019-10-29 0

    FLYNN JAMES E

    DEERFIELD MGMT IV, L.P.

    DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

    DEERFIELD PRIVATE DESIGN FUND IV, L.P.

    DEERFIELD MGMT L.P.

    DEERFIELD SPECIAL SITUATIONS FUND, L.P.

    DEERFIELD PARTNERS, L.P.

    • 10% Owner
    • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
    No longer subject to file 2019-10-24 0

    FLYNN JAMES E

    DEERFIELD MGMT IV, L.P.

    DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

    DEERFIELD PRIVATE DESIGN FUND IV, L.P.

    DEERFIELD MGMT L.P.

    DEERFIELD SPECIAL SITUATIONS FUND, L.P.

    • 10% Owner
    • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
    0 2019-10-24 0

    5AM VENTURES V, L.P.

    5AM PARTNERS V, LLC

    PARMAR KUSH

    ROCKLAGE SCOTT M

    SCHWAB ANDREW J.

    • 10% Owner
    0 2019-10-24 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    CABALETTA BIO INC CABA 2022-08-12 22:15:03 UTC -0.2116 2.5316 1000000
    CABALETTA BIO INC CABA 2022-08-12 21:45:04 UTC -0.2116 2.5316 1000000
    CABALETTA BIO INC CABA 2022-08-12 21:15:04 UTC -0.2116 2.5316 1000000
    CABALETTA BIO INC CABA 2022-08-12 20:45:04 UTC -0.2116 2.5316 1000000
    CABALETTA BIO INC CABA 2022-08-12 20:15:05 UTC -0.2116 2.5316 1000000
    CABALETTA BIO INC CABA 2022-08-12 19:45:03 UTC -0.2116 2.5316 1000000
    CABALETTA BIO INC CABA 2022-08-12 19:15:05 UTC -0.2116 2.5316 1000000
    CABALETTA BIO INC CABA 2022-08-12 18:45:03 UTC -0.2116 2.5316 1000000
    CABALETTA BIO INC CABA 2022-08-12 18:15:04 UTC -0.2116 2.5316 1000000
    CABALETTA BIO INC CABA 2022-08-12 17:45:04 UTC -0.2116 2.5316 1000000
    CABALETTA BIO INC CABA 2022-08-12 17:15:05 UTC -0.2116 2.5316 1000000
    CABALETTA BIO INC CABA 2022-08-12 16:45:04 UTC -0.2338 2.5538 1000000
    CABALETTA BIO INC CABA 2022-08-12 16:15:04 UTC -0.2338 2.5538 1000000
    CABALETTA BIO INC CABA 2022-08-12 15:45:04 UTC -0.2338 2.5538 550000
    CABALETTA BIO INC CABA 2022-08-12 15:15:05 UTC -0.2338 2.5538 550000
    CABALETTA BIO INC CABA 2022-08-12 14:45:04 UTC -0.2338 2.5538 550000
    CABALETTA BIO INC CABA 2022-08-12 14:15:05 UTC -0.2338 2.5538 550000
    CABALETTA BIO INC CABA 2022-08-12 13:45:04 UTC -0.3303 2.6503 550000
    CABALETTA BIO INC CABA 2022-08-12 13:15:04 UTC -0.3303 2.6503 550000
    CABALETTA BIO INC CABA 2022-08-12 12:45:04 UTC -0.3303 2.6503 550000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    Elevate your investments